Welcome to our dedicated page for Wenyuan Grp SEC filings (Ticker: WYGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Wenyuan Grp's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Wenyuan Grp's regulatory disclosures and financial reporting.
Wenyuan Group Corp. notified the SEC that it cannot timely file its Form 10-K for the year ending December 31, 2025 because it was unable to obtain necessary financial information. The company states it anticipates submitting the filing within the extension period provided by Rule 12b-25.
Wenyuan Group Corp. (WYGC) filed its quarterly report for the period ended September 30, 2025. The company reported no revenue for both the three- and nine-month periods, compared with $67,968 in offline product sales in the first nine months of 2024, reflecting a halt in its cultural and health product business.
Net loss narrowed to $239,602 for the nine months ended September 30, 2025 from $882,004 a year earlier, mainly because 2024 included $570,000 of share-based compensation. Cash fell to $7,608 with a working capital deficit of $305,645 and an accumulated deficit of $21,465,393, leading management to state there is substantial doubt about the company’s ability to continue as a going concern. The company also recorded a litigation reserve of approximately $266,869 related to a Chinese court ruling over an office suite purchase.